Crown Laboratories acquires Keri from GlaxoSmithKline
JOHNSON CITY, Tenn. – Crown Laboratories, a leading, fully integrated skin care company, Wednesday announced it has acquired the North American rights for Keri from GlaxoSmithKline (GSK) and received an equity investment from Greenspring Associates.